Long-acting injectable PrEP approved for use on NHS in England and Wales
The National Institute for Health and Care Excellence (NICE) has approved the first long-acting injectable form of HIV prevention for use on the NHS in England and Wales. The treatment, administered every two months, offers a vital alternative to daily oral PrEP tablets, which some individuals are unable to take